Influence of the preparation method on the physicochemical properties of econazole-loaded poly(butyl cyanoacrylate) colloidal nanoparticles

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 413, Issue , 2012, Pages 260-265

  Yordanov, Georgi ^a  

^a UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Dextran 40; Econazole; Emulsion polymerization; Nanoparticles; Nanoprecipitation; Poloxamer 188; Poly(butyl cyanoacrylate); Polysorbate 80

Indexed keywords

ADHESIVES; BIOMATERIALS; DEXTRAN; EMULSION POLYMERIZATION; EMULSIONS; POLYMER BLENDS;

BUTYL CYANOACRYLATE; ECONAZOLE; NANOPRECIPITATION; POLOXAMER; POLYSORBATE 80;

NANOPARTICLES;

DEXTRAN 40; ECONAZOLE; NANOPARTICLE; POLOXAMER; POLY(BUTYL CYANOACRYLATE); POLYSORBATE 80; UNCLASSIFIED DRUG;

ARTICLE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG SYNTHESIS; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYMERIZATION; PRECIPITATION; PRIORITY JOURNAL; ZETA POTENTIAL;

EID: 84867102456     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2011.12.060     Document Type: Article

References (33)

1. Thienpont D., Van Cutsem J., Van Nueten J.M., Niemegeers C.J., Marsboom R. Biological and toxicological properties of econazole, a broad-spectrum antimycotic. Arzneimittel-Forsch. 1975, 25:224-230.
2. Heel R.C., Brogden R.N., Speight T.M., Avery G.S. Econazole: a review of its antifungal activity and therapeutic efficacy. Drugs 1978, 16:177-201.
3. Borgers M. Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev. Infect. Dis. 1980, 2:520-534.
4. Pandey R., Ahmad Z., Sharma S., Khuller G.K. Nano-encapsulation of azole antifungals: potential applications to improve oral drug delivery. Int. J. Pharm. 2005, 301:268-276.
5. Prow T., Grice J., Lin L., Faye R., Butler M., Becker W., Wurm E., Yoong C., Robertson T., Soyer H., Roberts M. Nanoparticles and microparticles for skin drug delivery. Adv. Drug Deliv. Rev. 2011, 63:470-491.
6. Luo D.Q., Guo J.H., Wang F.J., Jin Z.X., Cheng X.L., Zhu J.C., Peng C.Q., Zhang C. Anti-fungal efficacy of polybutylcyanoacrylate nanoparticles of allicin and comparison with pure allicin. J. Biomater. Sci. Polym. Ed. 2009, 20:21-31.
7. Xu N., Gu J., Zhu Y., Wen H., Ren Q., Chen J. Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice. Int. J. Nanomed. 2011, 6:905-913.
8. Ahmad Z., Pandey R., Sharma S., Khuller G.K. Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles. Int. J. Antimicrob. Agents 2008, 31:142-146.
9. Bachhav Y.G., Mondon K., Kalia Y.N., Gurny R., Möller M. Novel micelle formulations to increase cutaneous bioavailability of azole antifungals. J. Control. Release 2011, 153:126-132.
10. Piemi M.P.Y., Korner D., Benita S., Marty J.-P. Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J. Control. Release 1999, 58:177-187.
11. Cogswell S., Berger S., Waterhouse D., Bally M.B., Wasan E.K. A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a Breast Cancer Xenograft Model. Pharm. Res. 2006, 23:2575-2585.
12. Verma P., Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine: NBM 2011, 10.1016/j.nano.2011.07.004.
13. Sanna V., Caria G., Mariani A. Effect of lipid nanoparticles containing fatty alcohols having different chain length on the ex vivo skin permeability of econazole nitrate. Powder Technol. 2010, 201:32-36.
14. Vauthier C., Dubernet C., Fattal E., Pinto-Alphandary H., Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev. 2003, 55:519-548.
15. Nicolas J., Couvreur P. Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines, Wiley interdisciplinary reviews. Nanomed. Nanobiotechnol. 2009, 1:111-127.
16. Murthy R.S.R., Reddy L.H. Poly(alkyl cyanoacrylate) nanoparticles for delivery of anti-cancer drugs. Nanotechnology for Cancer Therapy. 2006, 251-288. CRC Press. M.M. Amiji (Ed.).
17. Chaudhari K., Ukawala M., Manjappa A., Kumar A., Mundada P., Mishra A., Mathur R., Mönkkönen J., Murthy R.S.R. Opsonization, biodistribution, cellular uptake and apoptosis study of PEGylated PBCA nanoparticle as potential drug delivery carrier. Pharm. Res. 2012, 29(1):53-68.
18. He W., Jiang X., Zhang Z.-R. Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin. J. Pharm. Sci. 2008, 97:2250-2259.
19. Arias J.L., Gallardo V., Ruiz M.A., Delgado A.V. Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-fluorouracil delivery systems for active targeting. Eur. J. Pharm. Biopharm. 2008, 69:54-63.
20. Arias J.L., Ruiz Ma.A., López-Viota M., Delgado A.V. Poly(alkylcyanoacrylate) colloidal particles as vehicles for antitumour drug delivery: a comparative study. Colloid Surf. B 2008, 62:64-70.
21. Arias J.L., Linares-Molinero F., Gallardo V., Delgado A.V. Study of carbonyl iron/poly(butyl cyanoacrylate) (core/shell) particles as anticancer drug delivery systems. Loading and release properties. Eur. J. Pharm. Sci. 2008, 33:252-261.
22. Miyazaki S., Takahashi A., Kubo W., Bachynsky J., Löbenberg R. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. J. Pharm. Pharm. Sci. 2003, 6:238-245.
23. Yordanov G., Dushkin C. Preparation of poly(butylcyanoacrylate) drug carriers by nanoprecipitation using a pre-synthesized polymer and different colloidal stabilizers. Colloid Polym. Sci. 2010, 288:1019-1026.
24. Rao J.P., Geckeler K.E. Polymer nanoparticles: preparation techniques and size-control parameters. Prog. Polym. Sci. 2011, 36:887-913.
25. Couvreur P., Kante B., Roland M., Guiot P., Baudhuin P., Speiser P. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 1979, 31:331-332.
26. Behan N., Birkinshaw C., Clarke N. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation. Biomaterials 2001, 22:1335-1344.
27. Douglas S.J., Illum L., Davis S.S., Kreuter J., Particle Size Size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: I. Influence of physicochemical factors. J. Colloid Interface Sci. 1984, 101:149-158.
28. Douglas S.J., Illum L., Davis S.S. Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles: II. Influence of Stabilizers. J. Colloid Interface Sci. 1985, 103:154-163.
29. Hansali F., Poisson G., Wu M., Bendedouch D., Marie E. Miniemulsion polymerizations of n-butyl cyanoacrylate via two routes: towards a control of particle degradation. Colloid Surf. B 2011, 88:332-338.
30. Yordanov G., Bedzhova Z., Dushkin C. Preparation and physicochemical characterization of novel chlorambucil-loaded nanoparticles of poly(butylcyanoacrylate). Colloid Polym. Sci. 2010, 288:893-899.
31. Arias J.L., Gallardo V., Linares-Molinero F., Delgado A.V. Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles. J. Colloid Interface Sci. 2006, 299:599-607.
32. Yang S.C., Ge H.X., Hu Y., Jiang X.Q., Yang C.Z. Formation of positively charged poly(butyl cyanoacrylate) nanoparticles stabilized with chitosan. Colloid Polym. Sci. 2000, 278:285-292.
33. Yordanov G., Abrashev N., Dushkin C. Poly(n-butylcyanoacrylate) submicron particles loaded with ciprofloxacin for potential treatment of bacterial infections. Prog. Colloid Polym. Sci. 2010, 137:53-59.